These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7495643)

  • 1. Absolute configurations and conformations of the opioid agonist and antagonist enantiomers of picenadol.
    Froimowitz M; Cody V
    Chirality; 1995; 7(7):518-25. PubMed ID: 7495643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantiomeric conformers of the opioid agonist ketobemidone HCl in the crystal state.
    Froimowitz M; Cody V
    Chirality; 1993; 5(7):560-4. PubMed ID: 7902122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists.
    Thomas JB; Mascarella SW; Rothman RB; Partilla JS; Xu H; McCullough KB; Dersch CM; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 1998 May; 41(11):1980-90. PubMed ID: 9599247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic (4aR,10bS)-cis- and (4aS,10bS)-trans-octahydrobenzo[F]quinolines have similar pharmacophores.
    Froimowitz M; Deng Y; Jacob JN; Li N; Cody V
    Drug Des Discov; 1995 Aug; 13(1):73-81. PubMed ID: 8882902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationships of a new series of 2alpha-substituted trans-4,5-dimethyl-4-(3-hydroxyphenyl)piperidine as mu-selective opioid antagonists.
    Le Bourdonnec B; Goodman AJ; Michaut M; Ye HF; Graczyk TM; Belanger S; DeHaven RN; Dolle RE
    Bioorg Med Chem Lett; 2006 Feb; 16(4):864-8. PubMed ID: 16298525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine.
    Thomas JB; Fall MJ; Cooper JB; Rothman RB; Mascarella SW; Xu H; Partilla JS; Dersch CM; McCullough KB; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 1998 Dec; 41(26):5188-97. PubMed ID: 9857089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands.
    Shenderovich MD; Liao S; Qian X; Hruby VJ
    Biopolymers; 2000 Jun; 53(7):565-80. PubMed ID: 10766952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute configuration and conformation of the pure opioid antagonist (+)-2,9 alpha-dimethyl-5-(m-hydroxyphenyl)morphan.
    Froimowitz M; Pangborn W; Cody V
    Chirality; 1992; 4(6):377-83. PubMed ID: 1449951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.
    Kolhatkar RB; Ghorai SK; George C; Reith ME; Dutta AK
    J Med Chem; 2003 May; 46(11):2205-15. PubMed ID: 12747792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformation-activity study of 4-phenylpiperidine analgesics.
    Froimowitz M
    J Med Chem; 1982 Oct; 25(10):1127-33. PubMed ID: 7143349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists.
    Le Bourdonnec B; Goodman AJ; Michaut M; Ye HF; Graczyk TM; Belanger S; Herbertz T; Yap GP; DeHaven RN; Dolle RE
    J Med Chem; 2006 Dec; 49(25):7278-89. PubMed ID: 17149858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereochemical studies on medicinal agents. 25. Absolute configuration and analgetic potency of beta-1,2-dimethyl-2-phenyl-4-(propionyloxy)piperidine enantiomers.
    Fries DS; Dodge RP; Hope H; Portoghese PS
    J Med Chem; 1982 Jan; 25(1):9-12. PubMed ID: 6283082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonist.
    Thomas JB; Atkinson RN; Vinson NA; Catanzaro JL; Perretta CL; Fix SE; Mascarella SW; Rothman RB; Xu H; Dersch CM; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 2003 Jul; 46(14):3127-37. PubMed ID: 12825951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Substituted 9beta-methyl-5-(3-hydroxyphenyl)morphans are opioid receptor pure antagonists.
    Thomas JB; Zheng X; Mascarella SW; Rothman RB; Dersch CM; Partilla JS; Flippen-Anderson JL; George CF; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 1998 Oct; 41(21):4143-9. PubMed ID: 9767649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition in humans of racemic picenadol, an opioid analgesic.
    Franz PM; Anliker SL; Callaghan JT; DeSante KA; Dhahir PH; Nelson RL; Rubin A
    Drug Metab Dispos; 1990; 18(6):968-73. PubMed ID: 1981546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Na+ modulation, inverse agonism, and anorectic potency of 4-phenylpiperidine opioid antagonists.
    Emmerson PJ; McKinzie JH; Surface PL; Suter TM; Mitch CH; Statnick MA
    Eur J Pharmacol; 2004 Jun; 494(2-3):121-30. PubMed ID: 15212965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and configuration of racemic and optically active analgesic cycloaminoalkylnaphthalenes.
    Ghislandi V; Collina S; Azzolina O; Barbieri A; Lanza E; Tadini C
    Chirality; 1999; 11(1):21-8. PubMed ID: 9914649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational analysis of the opioid phenylmorphan and its 9 alpha-methyl analogue in solution using high-resolution nuclear magnetic resonance spectroscopy.
    DiMeglio CM; Froimowitz M; Makriyannis A
    Pharm Res; 1993 Aug; 10(8):1200-5. PubMed ID: 8415408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereochemical influences upon the opioid ligand activities of 4-alkyl-4-arylpiperidine derivatives.
    Casy AF; Dewar GH; al Deeb OA
    Chirality; 1989; 1(3):202-8. PubMed ID: 2561991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (1R,3R,4S)-1-benzyl-3-(tert-butyldimethylsilyloxy)-4-(hydroxymethyl)pyrrolidine-borane: novel B-H...H-O hydrogen bonding.
    Gainsford GJ; Luxenburger A; Woolhouse AD
    Acta Crystallogr C; 2010 Aug; 66(Pt 8):o418-20. PubMed ID: 20679720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.